Correlation Between Denali Therapeutics and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Candel Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Candel Therapeutics.
Diversification Opportunities for Denali Therapeutics and Candel Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Denali and Candel is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Candel Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Candel Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 1.88 times less risky than Candel Therapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Candel Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 465.00 in Candel Therapeutics on September 12, 2024 and sell it today you would lose (4.00) from holding Candel Therapeutics or give up 0.86% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Denali Therapeutics vs. Candel Therapeutics
Performance |
Timeline |
Denali Therapeutics |
Candel Therapeutics |
Denali Therapeutics and Candel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Denali Therapeutics and Candel Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |